Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect to chemotherapy treatment. It can cause symptoms that range from sensitivity to touch and numbness to neuropathic pain in ...

Discordance Between the Initial Diagnosis of Sarcomas and Subsequent Histopathological Revision and Molecular Analyses in a Sarcoma Reference Center in Brazil In this prospective study of 170 patients ...

“We plan to explore the efficacy of ricolinostat in diabetic peripheral neuropathy patients first,” Jarpe said. “Later we will expand into chemotherapy induced neuropathy and CMT2.

View all available purchase options and get full access to this article. The following represents disclosure information provided by authors of this manuscript. All relationships are considered ...

Chemotherapy-induced peripheral neuropathy (CIPN) is a common adverse effect for patients undergoing cancer treatments, and ...

Lavoie Smith and colleagues (2013) examined the effect of duloxetine on patients with chemotherapy-induced painful peripheral neuropathy. The authors designed a randomized, double-blind ...

Considering taking supplements to treat chemotherapy induced peripheral neuropathy? Below is a list of common natural remedies used to treat or reduce the symptoms of chemotherapy induced ...

Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to ...

Additionally, other clinical and non-clinical data suggest BXQ-350 has activity in chemotherapy-induced peripheral neuropathy ...

Some research suggests more than two-thirds of patients suffer chemotherapy-induced peripheral neuropathy - and a 2019 study in the journal Pain reported about 30 per cent of patients will still ...

Gorgas, President and CEO of Artelo Biosciences. "Starting with ART26.12, our promising Fatty Acid Binding Protein 5 (FABP5) ...